This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Knowing when to save and when to invest is crucial for financial success. Learn how to optimize your strategy for maximum returns.
28,655 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
MillerKnoll stock crashed today after a quarterly miss and softer guidance rattled investors. This deep dive explains...
New documents reveal Epstein used elite ties to influence major philanthropy groups, raising questions about governan...
BIT Capital trimmed a large Lemonade stake in the first quarter, revealing how institutional moves can influence vola...
Former Detroit Mayor Mike Duggan suspends his Michigan governor bid amid rising fuel costs and a toxic partisan clima...
Rising college costs push borrowers to weigh federal vs private loans. This guide breaks down risks, benefits, and cu...
Looking for value and growth in one parcel? This guide dives into the best growth etfs under $20, how to evaluate the...
Microsoft delivered a powerful May with a 10.4% jump, but June brought a dampening mood. This article breaks down wha...
Oracle stock dips despite a swelling backlog. This guide explains what backlog means, why the stock reacts, and how i...
The U.K. moves to bar under-16s from major platforms, setting up a widening policy shift that could reshape families’...
Dell fell about 6% as memory costs squeezed margins, while Western Digital rose around 5% on continued AI-driven dema...
CoreWeave unleashed resilient US-scale growth with a massive backlog, while Nebius posted stronger margins on a small...